Reaction
Urine Flow Decreased reporting signals
As of the last recalculation, Urine Flow Decreased appears in 2,349 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is MIRABEGRON (PRR 29.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mirabegron | 121 | 29.2 | 29.2 |
| Vibegron | 25 | 27.9 | 28.0 |
| Fesoterodine Fumarate | 33 | 27.4 | 27.4 |
| Relugolix | 44 | 16.8 | 16.9 |
| Finasteride | 108 | 16.6 | 16.6 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 28 | 15.0 | 15.0 |
| Atomoxetine Hydrochloride | 38 | 14.4 | 14.4 |
| Tamsulosin Hydrochloride | 26 | 11.4 | 11.4 |
| Umeclidinium | 11 | 10.9 | 10.9 |
| Quinapril Hydrochloride | 9 | 10.1 | 10.2 |
| Tadalafil | 109 | 10.1 | 10.1 |
| Loratadine And Pseudoephedrine Sulfate | 7 | 7.8 | 7.8 |
| Bicalutamide | 13 | 7.6 | 7.6 |
| Doxazosin Mesylate | 30 | 7.4 | 7.4 |
| Lisinopril And Hydrochlorothiazide | 7 | 6.1 | 6.1 |
| Doxazosin | 19 | 6.1 | 6.1 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 28 | 6.0 | 6.1 |
| Fexofenadine | 11 | 5.9 | 5.9 |
| Rasagiline Mesylate | 7 | 5.6 | 5.6 |
| Tiotropium Bromide Inhalation Spray | 7 | 5.5 | 5.6 |
| Desvenlafaxine Succinate | 16 | 5.3 | 5.3 |
| Tiotropium Bromide | 73 | 4.8 | 4.8 |
| Enzalutamide | 30 | 4.6 | 4.6 |
| Abiraterone | 7 | 4.6 | 4.6 |
| Leuprolide Acetate | 34 | 3.9 | 3.9 |
| Apalutamide | 5 | 3.8 | 3.8 |
| Vortioxetine | 7 | 3.7 | 3.7 |
| Pseudoephedrine Hydrochloride | 4 | 3.5 | 3.5 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 4 | 3.4 | 3.4 |
| Pseudoephedrine Hcl | 4 | 3.2 | 3.2 |
| Canagliflozin | 9 | 2.7 | 2.7 |
| Abiraterone Acetate | 12 | 2.6 | 2.6 |
| Pirfenidone | 9 | 2.0 | 2.0 |